Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)

Chest

Volumn 133, Issue 6 SUPPL. 6, 2008, Pages 110S-112S

  Hirsh, Jack ^a   Guyatt, Gordon ^b   Albers, Gregory W ^c   Harrington, Robert ^d   Schünemann, Holger J ^e  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; THROMBOEMBOLISM; THROMBOSIS; VALVULAR HEART DISEASE;

EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; THROMBOLYTIC THERAPY;

EID: 45949108549     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0652     Document Type: Article

References (3)

1. Schunemann HJ, Cook D, Guyatt G. Methodology for anti-thrombotic and thrombolytic therapy guideline development: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133(suppl):113S-122S
2. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006; 129:174-181
3. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches; The GRADE Working Group. BMC Health Serv Res 2004; 4:38